🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for Sepsis

Recruitingn/aAges 18 Years - 80 YearsAllAin Shams University
NCT07089524 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Aim of this study is to predict the prognostic values of Neutrophil/ Lymphocyte ratio and Lactate/Albumin ratio in the outcome of patients with sepsis and septic shock with lower respiratory tract infection, also to compare between them regarding sensitivity and specificity.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults with lower respiratory tract infection * Confirmed septic patients (under the third international consensus definitions of sepsis and septic shock), * Admitted to intensive care unit. * Age (18-80) years. * Both genders. Exclusion Criteria: * Age: \< 18 years old, \> 80 years old * Patient refusal. * Pregnancy. * Malignancy. * Pathology that could affect serum albumin concentrations prior to ICU admission as Malnutrition * Nephrotic syndrome * Liver Cirrhosis * Intestinal resection surgeries
💊

What it tests

  • Not listed
📍

Where

1 site
Ain Shams university
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy